| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |